543207 — Natural Biocon (India) Income Statement
0.000.00%
- IN₹291.86m
- IN₹286.15m
- IN₹135.34m
- 46
- 24
- 58
- 37
Annual income statement for Natural Biocon (India), fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0 | 1.32 | 4.82 | 12.5 | 135 |
Cost of Revenue | |||||
Gross Profit | 0 | 0.431 | 1.94 | 3.75 | 8.65 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 0.316 | 1.28 | 3.93 | 10.1 | 133 |
Operating Profit | -0.316 | 0.043 | 0.887 | 2.48 | 2.25 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -0.317 | 0.037 | 0.879 | 2.47 | 2.25 |
Provision for Income Taxes | |||||
Net Income After Taxes | -0.317 | 0.028 | 0.659 | 1.79 | 1.53 |
Net Income Before Extraordinary Items | |||||
Net Income | -0.317 | 0.028 | 0.659 | 1.79 | 1.53 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -0.317 | 0.028 | 0.659 | 1.79 | 1.53 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.028 | 0.002 | 0.058 | 0.157 | 0.134 |